课题基金 / 基金详情

肿瘤相关巨噬细胞调控GAP43介导神经生长活动在骨癌痛中的作用及机制研究

批准号:
82071248
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
宋宗斌
依托单位:
学科分类:
感觉障碍、疼痛与镇痛
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
宋宗斌

项目摘要

结项摘要

宋宗斌的其他基金

相似基金

相关文献

中文摘要
骨癌痛(BCP)疼痛剧烈且治疗效果不佳。骨肿瘤局部神经异常生长分化参与癌痛发生。生长相关蛋白43(GAP43)是神经生长标记物。本项目前期研究发现:抑制GAP43可减少神经损伤后异常自发放电并缓解疼痛;BCP患者肿瘤骨GAP43阳性神经纤维增生活跃;BCP大鼠背根节GAP43上调,骨髓腔肿瘤相关巨噬细胞(TAMs)浸润及IL-6表达增加;抑制TAMs可缓解BCP,减少IL-6, PKCγ及GAP43表达;体外实验发现TAMs可促进神经生长及兴奋性增加。因此,我们提出TAMs调控GAP43介导神经生长参与BCP:TAMs分泌IL-6作用于局部神经元,通过PKCγ导致GAP43上调并激活,促进神经生长,神经元兴奋性异常增加并自发放电,导致BCP。我们拟探寻BCP大鼠TAMs表型及功能变化调控局部神经生长分子机制,研究GAP43介导神经生长活动在BCP中的作用,为癌痛治疗及研究寻找潜在靶点。
英文摘要
Bone cancer pain (BCP) is severe and hard to control. Bone cancer induced nerve fiber sprouting and differentiation are involved in cancer pain. Growth associated protein 43 (GAP 43) plays a key role in axonal growth during nerve development and regeneration. In the preliminary study, we found that density of GAP43 positive nerve fibers were obviously increased in the periosteum of the BCP patient; inhibition of GAP43 can significantly relieve the spontaneous neuronal activity and pain after nerve injury. Expression of GAP43 was up-regulated in dorsal root ganglia, and infiltration of tumor-associated macrophages (TAMs) and IL-6 expression was increased in bone marrow cavity of BCP rats. Inhibition of TAMs with trabectedin can alleviate BCP and down-regulated the expression of IL-6, PKCγ and GAP43 in BCP rats. Furthermore, we found that TAMs promoted nerve growth, increased expression of GAP43 and neuronal excitability in vitro. We hypothesize that TAMs regulating GAP43 mediated nerve growth and play a key role in the BCP: TAMs release IL-6 and act on surrounding neuron, which leads to the upregulation and activation of GAP43 through PKCγ, promotes the abnormal nerve growth activity, increases the excitability of neuron, and spontaneous activity, which ultimately result in BCP. In the proposed study, we plan to observe the phenotypic and functional of TAMs, explore molecular mechanisms by which TAMs regulate nerve growth, and study the role of GAP43 mediated nerve growth on neuronal excitability and electrophysiological characteristics in BCP. Our proposed study will help to unveil the mechanism of BCP, and provide potential targets for the treatment.
晚期肿瘤往往伴随明显疼痛,程度剧烈且临床治疗效果差,严重影响患者生活质量。本项目以肿瘤相关巨噬细胞为切入点,重点探究骨癌痛发生发展过程中肿瘤微环境代谢及炎症反应的变化,探寻炎症反介导的肿瘤与神经相互作用在骨癌痛中的作用及其机制。我们通过股骨注射肺癌细胞构建了骨癌痛小鼠模型,伴随肿瘤细胞的增殖出现了明显的局部骨质破坏,小鼠肿瘤侧后肢出现时间依赖性的痛觉过敏及自发性疼痛,背根神经节TRPV1表达上调。溶血磷脂酰胆碱(LPC)是卵磷脂在体内代谢的中间产物,是具有生物活性的重要促炎脂质,参与神经炎性反应。本项目对骨癌痛小鼠荷瘤骨行脂质代谢组学分析,发现肿瘤微环境中LPC明显富集。肿瘤微环境中巨噬细胞是LPC关键来源。探究LPC功能发现,足底注射LPC可剂量依赖性的诱发痛觉过敏。骨癌痛小鼠腹腔注射LPC抑制剂Darapladib可减少LPC含量并缓解小鼠骨癌痛,但其并不能影响肿瘤进展。本项目研究证实了肿瘤微环境巨噬细胞的神经炎性反应在骨癌痛中扮演重要角色,发现溶血磷脂酰胆碱是其中关键分子,上述结果加深了对骨癌痛神经机制的理解,也为临床防治癌痛提供了重要的研究思路及潜在的干预靶标。
ALKBH5介导海马SHANK2 m6A修饰在GDNF调控骨癌痛大鼠抑郁样行为中的作用及机制研究
  • 批准号:
    82371238
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    宋宗斌
  • 依托单位:
脑内GDNF对骨癌痛大鼠抑郁样行为的影响
  • 批准号:
    2018JJ3836
  • 项目类别:
    省市级项目
  • 资助金额:
    0.0万元
  • 批准年份:
    2018
  • 负责人:
    宋宗斌
  • 依托单位:
GDNF通过激活Ret介导信号通路参与骨癌痛-吗啡耐受的机制研究
  • 批准号:
    81300958
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    宋宗斌
  • 依托单位:
国内基金
海外基金